dc.contributor.author | D'Hollander, Antoine | |
dc.contributor.author | Jans, Hilde | |
dc.contributor.author | Vande Velde, Greetje | |
dc.contributor.author | Verstraete, Charlotte | |
dc.contributor.author | Massa, Sam | |
dc.contributor.author | Stakenborg, Tim | |
dc.contributor.author | Muyldermans, Serge | |
dc.contributor.author | Lagae, Liesbet | |
dc.contributor.author | Himmelreich, Uwe | |
dc.date.accessioned | 2021-10-24T04:17:37Z | |
dc.date.available | 2021-10-24T04:17:37Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 0142-9612 | |
dc.identifier.uri | https://imec-publications.be/handle/20.500.12860/28243 | |
dc.source | IIOimport | |
dc.title | Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars | |
dc.type | Journal article | |
dc.contributor.imecauthor | D'Hollander, Antoine | |
dc.contributor.imecauthor | Jans, Hilde | |
dc.contributor.imecauthor | Stakenborg, Tim | |
dc.contributor.imecauthor | Lagae, Liesbet | |
dc.contributor.orcidimec | Stakenborg, Tim::0000-0001-9878-9078 | |
dc.source.peerreview | yes | |
dc.source.beginpage | 15 | |
dc.source.endpage | 23 | |
dc.source.journal | Biomaterials | |
dc.source.volume | 123 | |
dc.identifier.url | http://dx.doi.org/10.1016/j.biomaterials.2017.01.007 | |
imec.availability | Published - imec | |